Display options
Cite
Henriquez S, Zerbit J, Bruel T, et al. Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against Alpha and Delta variants in Multiple Myeloma patients. Blood. 2021;doi: 10.1182/blood.2021013714.
Henriquez, S., Zerbit, J., Bruel, T., Ouedrani, A., Planas, D., Deschamps, P., Staropoli, I., Hadjadj, J., Varet, B. R., Ermak, N., Bouscary, D., Willems, L., Fouquet, G., Decroocq, J., Franchi, P., Deau, B., Terrier, B., Tamburini, J., Chatenoud, L., Schwartz, O., & Vignon, M. (2021). Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against Alpha and Delta variants in Multiple Myeloma patients. Blood, . https://doi.org/10.1182/blood.2021013714
Henriquez, Soledad, et al. "Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against Alpha and Delta variants in Multiple Myeloma patients." Blood vol. (2021). doi: https://doi.org/10.1182/blood.2021013714
Henriquez S, Zerbit J, Bruel T, Ouedrani A, Planas D, Deschamps P, Staropoli I, Hadjadj J, Varet BR, Ermak N, Bouscary D, Willems L, Fouquet G, Decroocq J, Franchi P, Deau B, Terrier B, Tamburini J, Chatenoud L, Schwartz O, Vignon M. Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against Alpha and Delta variants in Multiple Myeloma patients. Blood. 2021 Dec 14; doi: 10.1182/blood.2021013714. Epub 2021 Dec 14. PMID: 34905598; PMCID: PMC8674107.
Copy Download .nbib Format: NLM
Share it on

Blood. 2021 Dec 14; doi: 10.1182/blood.2021013714. Epub 2021 Dec 14.

Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against Alpha and Delta variants in Multiple Myeloma patients.

Blood

Soledad Henriquez, Jérémie Zerbit, Timothée Bruel, Amani Ouedrani, Delphine Planas, Paul Deschamps, Isabelle Staropoli, Jérôme Hadjadj, Bruno R Varet, Natalia Ermak, Didier Bouscary, Lise Willems, Guillemette Fouquet, Justine Decroocq, Patricia Franchi, Benedicte Deau, Benjamin Terrier, Jérôme Tamburini, Lucienne Chatenoud, Olivier Schwartz, Marguerite Vignon

Affiliations

  1. Hopital Cochin, Paris, France.
  2. APHP Cochin Hospital, Paris, France.
  3. Vaccine Research Institute, Créteil, France.
  4. Université de Paris, CNRS UMR 8253 and INSERM UMR1151, Institut Necker-Enfants Malades, Paris, France.
  5. Institut Pasteur, Paris, France.
  6. Hôpital Necker, Paris, France.
  7. Université de Paris, CNRS UMR8104, INSERM U1016, Institut Cochin, Paris, France.
  8. cochin, paris, France.
  9. Hôpital Cochin, APHP, Paris, Paris, France.
  10. Université de Paris, Institut Cochin, CNRS UMR8104, INSERM U1016, F-75014 Paris, France, Paris, France.
  11. AP-HP.
  12. Hopital Cochin, PARIS, France.
  13. Université de Paris, INSERM, U970, PARCC, Paris, France.
  14. Université de Genève CMU Rue Michel Servet 1, Genève, Switzerland.
  15. Cochin, 75010, France.

PMID: 34905598 PMCID: PMC8674107 DOI: 10.1182/blood.2021013714

[No abstract available.]

Publication Types